Back to Top Skip to main content

2012 Meetings

Meeting Date  Drug Classes Under Review/Information for Manufacturers 
February 2012
  • ADHD/Narolepsy
  • Anti-platelet Therapy
  • Diabetes: Non-Insulin
New Drugs
  • Lastacaft
  • Nucynta ER
May 2012 
  • Sedative/Hypnotic
  • Tobacco Cessation Drugs

New Drugs

  • Gralise
  • Horizant
August 2012
  • Androgens-Anabolic Steroids
  • Anticoagulants
New Drugs
  • Bydureon
  • Duesis
  • Janumet XR
  • Jentadueto
  • Orencia
  • Sprix
  • Zioptan
November 2012
  • Hepatitis C Agents
  • Overactive Bladder Agents
  • Gastrointestinal-2 Agents
  • Diabetes: Non-Insulin
New Drugs
  • Oxtecta

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing: Download a PDF Reader or learn more about PDFs.